nodes	percent_of_prediction	percent_of_DWPC	metapath
Diphenhydramine—SLC22A2—Metformin—polycystic ovary syndrome	0.378	0.535	CbGbCtD
Diphenhydramine—SLC22A1—Metformin—polycystic ovary syndrome	0.328	0.465	CbGbCtD
Diphenhydramine—CYP2C19—urine—polycystic ovary syndrome	0.00773	0.103	CbGeAlD
Diphenhydramine—CYP1A2—urine—polycystic ovary syndrome	0.00631	0.0842	CbGeAlD
Diphenhydramine—CYP2C9—urine—polycystic ovary syndrome	0.00599	0.0799	CbGeAlD
Diphenhydramine—CYP2D6—urine—polycystic ovary syndrome	0.0045	0.06	CbGeAlD
Diphenhydramine—CYP2C18—vagina—polycystic ovary syndrome	0.00322	0.043	CbGeAlD
Diphenhydramine—CYP2C18—endocrine gland—polycystic ovary syndrome	0.00302	0.0402	CbGeAlD
Diphenhydramine—SLC22A1—adipose tissue—polycystic ovary syndrome	0.00214	0.0285	CbGeAlD
Diphenhydramine—SLC22A5—adrenal cortex—polycystic ovary syndrome	0.00185	0.0246	CbGeAlD
Diphenhydramine—SLC22A1—vagina—polycystic ovary syndrome	0.00178	0.0237	CbGeAlD
Diphenhydramine—CHRM2—endocrine gland—polycystic ovary syndrome	0.00169	0.0226	CbGeAlD
Diphenhydramine—SLC22A1—endocrine gland—polycystic ovary syndrome	0.00166	0.0222	CbGeAlD
Diphenhydramine—SLC22A5—endometrium—polycystic ovary syndrome	0.00165	0.022	CbGeAlD
Diphenhydramine—CYP2B6—adrenal cortex—polycystic ovary syndrome	0.0016	0.0214	CbGeAlD
Diphenhydramine—Chest discomfort—Metformin—polycystic ovary syndrome	0.00159	0.103	CcSEcCtD
Diphenhydramine—SLC22A5—pituitary gland—polycystic ovary syndrome	0.00149	0.0199	CbGeAlD
Diphenhydramine—SLC22A5—adipose tissue—polycystic ovary syndrome	0.00149	0.0198	CbGeAlD
Diphenhydramine—HRH1—endometrium—polycystic ovary syndrome	0.0014	0.0186	CbGeAlD
Diphenhydramine—CYP2C19—vagina—polycystic ovary syndrome	0.00137	0.0183	CbGeAlD
Diphenhydramine—SLC22A5—adrenal gland—polycystic ovary syndrome	0.00133	0.0178	CbGeAlD
Diphenhydramine—PTGS1—endometrium—polycystic ovary syndrome	0.00129	0.0173	CbGeAlD
Diphenhydramine—CYP2C19—endocrine gland—polycystic ovary syndrome	0.00128	0.0171	CbGeAlD
Diphenhydramine—HRH1—adipose tissue—polycystic ovary syndrome	0.00126	0.0168	CbGeAlD
Diphenhydramine—SLC22A5—female gonad—polycystic ovary syndrome	0.00124	0.0166	CbGeAlD
Diphenhydramine—SLC22A5—vagina—polycystic ovary syndrome	0.00124	0.0165	CbGeAlD
Diphenhydramine—Bifonazole—CYP17A1—polycystic ovary syndrome	0.0012	0.0703	CrCbGaD
Diphenhydramine—PTGS1—uterus—polycystic ovary syndrome	0.00119	0.0159	CbGeAlD
Diphenhydramine—PTGS1—pituitary gland—polycystic ovary syndrome	0.00117	0.0156	CbGeAlD
Diphenhydramine—PTGS1—adipose tissue—polycystic ovary syndrome	0.00117	0.0156	CbGeAlD
Diphenhydramine—CYP2B6—adrenal gland—polycystic ovary syndrome	0.00116	0.0154	CbGeAlD
Diphenhydramine—Clomifene—CYP11A1—polycystic ovary syndrome	0.00113	0.0665	CrCbGaD
Diphenhydramine—HRH1—adrenal gland—polycystic ovary syndrome	0.00113	0.0151	CbGeAlD
Diphenhydramine—Nasal congestion—Metformin—polycystic ovary syndrome	0.00112	0.0726	CcSEcCtD
Diphenhydramine—CYP2B6—vagina—polycystic ovary syndrome	0.00107	0.0143	CbGeAlD
Diphenhydramine—HRH1—female gonad—polycystic ovary syndrome	0.00105	0.0141	CbGeAlD
Diphenhydramine—HRH1—vagina—polycystic ovary syndrome	0.00105	0.014	CbGeAlD
Diphenhydramine—CYP1A2—endocrine gland—polycystic ovary syndrome	0.00105	0.014	CbGeAlD
Diphenhydramine—PTGS1—adrenal gland—polycystic ovary syndrome	0.00105	0.0139	CbGeAlD
Diphenhydramine—CYP2B6—endocrine gland—polycystic ovary syndrome	0.001	0.0134	CbGeAlD
Diphenhydramine—CYP2C9—endocrine gland—polycystic ovary syndrome	0.000994	0.0132	CbGeAlD
Diphenhydramine—HRH1—endocrine gland—polycystic ovary syndrome	0.00098	0.0131	CbGeAlD
Diphenhydramine—PTGS1—female gonad—polycystic ovary syndrome	0.000976	0.013	CbGeAlD
Diphenhydramine—PTGS1—vagina—polycystic ovary syndrome	0.00097	0.0129	CbGeAlD
Diphenhydramine—PTGS1—endocrine gland—polycystic ovary syndrome	0.000907	0.0121	CbGeAlD
Diphenhydramine—Sweating increased—Metformin—polycystic ovary syndrome	0.000861	0.0557	CcSEcCtD
Diphenhydramine—Modafinil—ADRA1B—polycystic ovary syndrome	0.000857	0.0504	CrCbGaD
Diphenhydramine—Phenoxybenzamine—ADRA1D—polycystic ovary syndrome	0.000832	0.0489	CrCbGaD
Diphenhydramine—CYP2D6—female gonad—polycystic ovary syndrome	0.000802	0.0107	CbGeAlD
Diphenhydramine—Drowsiness—Metformin—polycystic ovary syndrome	0.000788	0.051	CcSEcCtD
Diphenhydramine—Neuropathy peripheral—Metformin—polycystic ovary syndrome	0.000773	0.05	CcSEcCtD
Diphenhydramine—CYP2D6—endocrine gland—polycystic ovary syndrome	0.000746	0.00994	CbGeAlD
Diphenhydramine—Phenoxybenzamine—ADRA1B—polycystic ovary syndrome	0.00071	0.0417	CrCbGaD
Diphenhydramine—Doxepin—ADRA1D—polycystic ovary syndrome	0.000677	0.0398	CrCbGaD
Diphenhydramine—Chills—Metformin—polycystic ovary syndrome	0.000635	0.0411	CcSEcCtD
Diphenhydramine—Bifonazole—CYP19A1—polycystic ovary syndrome	0.000608	0.0358	CrCbGaD
Diphenhydramine—Trimipramine—ADRA1B—polycystic ovary syndrome	0.000606	0.0356	CrCbGaD
Diphenhydramine—Promazine—ADRA1D—polycystic ovary syndrome	0.000602	0.0354	CrCbGaD
Diphenhydramine—Clomifene—CYP19A1—polycystic ovary syndrome	0.000585	0.0344	CrCbGaD
Diphenhydramine—Vision blurred—Metformin—polycystic ovary syndrome	0.000581	0.0376	CcSEcCtD
Diphenhydramine—Doxepin—ADRA1B—polycystic ovary syndrome	0.000578	0.034	CrCbGaD
Diphenhydramine—Tremor—Metformin—polycystic ovary syndrome	0.000577	0.0373	CcSEcCtD
Diphenhydramine—Palpitations—Metformin—polycystic ovary syndrome	0.000545	0.0352	CcSEcCtD
Diphenhydramine—Imipramine—ADRA1D—polycystic ovary syndrome	0.000527	0.031	CrCbGaD
Diphenhydramine—Amitriptyline—ADRA1D—polycystic ovary syndrome	0.000524	0.0308	CrCbGaD
Diphenhydramine—Promazine—ADRA1B—polycystic ovary syndrome	0.000513	0.0302	CrCbGaD
Diphenhydramine—Benzphetamine—ADRA1A—polycystic ovary syndrome	0.0005	0.0294	CrCbGaD
Diphenhydramine—Toremifene—CYP1A1—polycystic ovary syndrome	0.000498	0.0293	CrCbGaD
Diphenhydramine—Thrombocytopenia—Metformin—polycystic ovary syndrome	0.000492	0.0318	CcSEcCtD
Diphenhydramine—Hyperhidrosis—Metformin—polycystic ovary syndrome	0.000486	0.0314	CcSEcCtD
Diphenhydramine—Anorexia—Metformin—polycystic ovary syndrome	0.000479	0.031	CcSEcCtD
Diphenhydramine—Phenoxybenzamine—ADRA1A—polycystic ovary syndrome	0.000478	0.0281	CrCbGaD
Diphenhydramine—Hypotension—Metformin—polycystic ovary syndrome	0.00047	0.0304	CcSEcCtD
Diphenhydramine—Levomethadyl Acetate—CYP19A1—polycystic ovary syndrome	0.000457	0.0269	CrCbGaD
Diphenhydramine—Paraesthesia—Metformin—polycystic ovary syndrome	0.000452	0.0292	CcSEcCtD
Diphenhydramine—Imipramine—ADRA1B—polycystic ovary syndrome	0.00045	0.0264	CrCbGaD
Diphenhydramine—Somnolence—Metformin—polycystic ovary syndrome	0.000447	0.0289	CcSEcCtD
Diphenhydramine—Amitriptyline—ADRA1B—polycystic ovary syndrome	0.000447	0.0263	CrCbGaD
Diphenhydramine—Dyspepsia—Metformin—polycystic ovary syndrome	0.000443	0.0286	CcSEcCtD
Diphenhydramine—Decreased appetite—Metformin—polycystic ovary syndrome	0.000437	0.0283	CcSEcCtD
Diphenhydramine—Fatigue—Metformin—polycystic ovary syndrome	0.000434	0.028	CcSEcCtD
Diphenhydramine—Clomifene—CYP1A1—polycystic ovary syndrome	0.00043	0.0253	CrCbGaD
Diphenhydramine—Constipation—Metformin—polycystic ovary syndrome	0.00043	0.0278	CcSEcCtD
Diphenhydramine—Feeling abnormal—Metformin—polycystic ovary syndrome	0.000414	0.0268	CcSEcCtD
Diphenhydramine—Trimipramine—ADRA1A—polycystic ovary syndrome	0.000408	0.024	CrCbGaD
Diphenhydramine—Urticaria—Metformin—polycystic ovary syndrome	0.0004	0.0258	CcSEcCtD
Diphenhydramine—Promethazine—ADRA1A—polycystic ovary syndrome	0.000393	0.0231	CrCbGaD
Diphenhydramine—Doxepin—ADRA1A—polycystic ovary syndrome	0.000389	0.0229	CrCbGaD
Diphenhydramine—Asthenia—Metformin—polycystic ovary syndrome	0.000361	0.0233	CcSEcCtD
Diphenhydramine—Warfarin—CYP1A1—polycystic ovary syndrome	0.000359	0.0211	CrCbGaD
Diphenhydramine—Promazine—ADRA1A—polycystic ovary syndrome	0.000346	0.0203	CrCbGaD
Diphenhydramine—Diarrhoea—Metformin—polycystic ovary syndrome	0.000344	0.0222	CcSEcCtD
Diphenhydramine—Dizziness—Metformin—polycystic ovary syndrome	0.000333	0.0215	CcSEcCtD
Diphenhydramine—Vomiting—Metformin—polycystic ovary syndrome	0.00032	0.0207	CcSEcCtD
Diphenhydramine—Rash—Metformin—polycystic ovary syndrome	0.000317	0.0205	CcSEcCtD
Diphenhydramine—Dermatitis—Metformin—polycystic ovary syndrome	0.000317	0.0205	CcSEcCtD
Diphenhydramine—Headache—Metformin—polycystic ovary syndrome	0.000315	0.0204	CcSEcCtD
Diphenhydramine—Imipramine—ADRA1A—polycystic ovary syndrome	0.000303	0.0178	CrCbGaD
Diphenhydramine—Amitriptyline—ADRA1A—polycystic ovary syndrome	0.000301	0.0177	CrCbGaD
Diphenhydramine—Nausea—Metformin—polycystic ovary syndrome	0.000299	0.0193	CcSEcCtD
Diphenhydramine—Cinnarizine—CYP1A1—polycystic ovary syndrome	0.000285	0.0167	CrCbGaD
Diphenhydramine—Phenoxybenzamine—ADRB2—polycystic ovary syndrome	0.000284	0.0167	CrCbGaD
Diphenhydramine—Tamoxifen—CYP19A1—polycystic ovary syndrome	0.00027	0.0159	CrCbGaD
Diphenhydramine—Methadone—CYP19A1—polycystic ovary syndrome	0.000268	0.0158	CrCbGaD
Diphenhydramine—Tamoxifen—CYP1A1—polycystic ovary syndrome	0.000199	0.0117	CrCbGaD
Diphenhydramine—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	4.67e-05	0.00025	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—LHB—polycystic ovary syndrome	4.66e-05	0.00025	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—GNRH1—polycystic ovary syndrome	4.63e-05	0.000248	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—AKR1C3—polycystic ovary syndrome	4.63e-05	0.000248	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	4.6e-05	0.000246	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—AKR1C1—polycystic ovary syndrome	4.59e-05	0.000246	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—GNRH1—polycystic ovary syndrome	4.56e-05	0.000244	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—CYP17A1—polycystic ovary syndrome	4.56e-05	0.000244	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—SRD5A1—polycystic ovary syndrome	4.55e-05	0.000244	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—SRD5A1—polycystic ovary syndrome	4.51e-05	0.000242	CbGpPWpGaD
Diphenhydramine—CYP2C18—Metabolism—CYP1A1—polycystic ovary syndrome	4.51e-05	0.000242	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—AKR1C1—polycystic ovary syndrome	4.49e-05	0.00024	CbGpPWpGaD
Diphenhydramine—HRH1—GPCR downstream signaling—GNAS—polycystic ovary syndrome	4.48e-05	0.00024	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—AKR1C3—polycystic ovary syndrome	4.44e-05	0.000238	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—SCT—polycystic ovary syndrome	4.44e-05	0.000238	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—AKR1C1—polycystic ovary syndrome	4.41e-05	0.000237	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCR downstream signaling—GNAS—polycystic ovary syndrome	4.41e-05	0.000236	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—ADRB2—polycystic ovary syndrome	4.38e-05	0.000235	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—CYP17A1—polycystic ovary syndrome	4.37e-05	0.000234	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—SCT—polycystic ovary syndrome	4.37e-05	0.000234	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—STAR—polycystic ovary syndrome	4.34e-05	0.000233	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—ADRB2—polycystic ovary syndrome	4.31e-05	0.000231	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—STAR—polycystic ovary syndrome	4.31e-05	0.000231	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	4.26e-05	0.000228	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—MTNR1B—polycystic ovary syndrome	4.24e-05	0.000227	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—SULT2A1—polycystic ovary syndrome	4.22e-05	0.000226	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—HMMR—polycystic ovary syndrome	4.21e-05	0.000225	CbGpPWpGaD
Diphenhydramine—CYP2C18—Metabolism—MTHFR—polycystic ovary syndrome	4.2e-05	0.000225	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—MTNR1B—polycystic ovary syndrome	4.17e-05	0.000223	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—FGF18—polycystic ovary syndrome	4.16e-05	0.000223	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—RBP4—polycystic ovary syndrome	4.13e-05	0.000221	CbGpPWpGaD
Diphenhydramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—polycystic ovary syndrome	4.11e-05	0.00022	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—FGF18—polycystic ovary syndrome	4.1e-05	0.00022	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—RRM2—polycystic ovary syndrome	4.09e-05	0.000219	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—PNPLA2—polycystic ovary syndrome	4.07e-05	0.000218	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—GNAS—polycystic ovary syndrome	4.07e-05	0.000218	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—RBP4—polycystic ovary syndrome	4.06e-05	0.000218	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—TH—polycystic ovary syndrome	4.06e-05	0.000218	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—HSD3B1—polycystic ovary syndrome	4.01e-05	0.000215	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—GNAS—polycystic ovary syndrome	4e-05	0.000214	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	3.97e-05	0.000213	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—SLC2A4—polycystic ovary syndrome	3.95e-05	0.000212	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—TH—polycystic ovary syndrome	3.94e-05	0.000211	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—YAP1—polycystic ovary syndrome	3.94e-05	0.000211	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—HMMR—polycystic ovary syndrome	3.87e-05	0.000207	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—SRD5A1—polycystic ovary syndrome	3.86e-05	0.000207	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—YAP1—polycystic ovary syndrome	3.85e-05	0.000207	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—HMMR—polycystic ovary syndrome	3.84e-05	0.000206	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—SLC2A4—polycystic ovary syndrome	3.83e-05	0.000205	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—GAB1—polycystic ovary syndrome	3.8e-05	0.000204	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—YAP1—polycystic ovary syndrome	3.79e-05	0.000203	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—NAMPT—polycystic ovary syndrome	3.79e-05	0.000203	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—TH—polycystic ovary syndrome	3.78e-05	0.000203	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	3.76e-05	0.000202	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—GAB1—polycystic ovary syndrome	3.74e-05	0.0002	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—CYP11A1—polycystic ovary syndrome	3.74e-05	0.0002	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—CYP19A1—polycystic ovary syndrome	3.71e-05	0.000199	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—HSD3B1—polycystic ovary syndrome	3.69e-05	0.000198	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—SLC2A4—polycystic ovary syndrome	3.68e-05	0.000197	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—STAR—polycystic ovary syndrome	3.68e-05	0.000197	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—LHB—polycystic ovary syndrome	3.66e-05	0.000196	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—HSD3B1—polycystic ovary syndrome	3.66e-05	0.000196	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	3.64e-05	0.000195	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—INSR—polycystic ovary syndrome	3.63e-05	0.000195	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	3.62e-05	0.000194	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—CYP19A1—polycystic ovary syndrome	3.61e-05	0.000193	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—HSD3B2—polycystic ovary syndrome	3.58e-05	0.000192	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—INSR—polycystic ovary syndrome	3.58e-05	0.000192	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—AKR1C3—polycystic ovary syndrome	3.53e-05	0.000189	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—CYP17A1—polycystic ovary syndrome	3.48e-05	0.000186	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—AKR1C1—polycystic ovary syndrome	3.47e-05	0.000186	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—CYP19A1—polycystic ovary syndrome	3.46e-05	0.000185	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—AKR1C3—polycystic ovary syndrome	3.45e-05	0.000185	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	3.43e-05	0.000184	CbGpPWpGaD
Diphenhydramine—CYP2C18—Metabolism—PPARG—polycystic ovary syndrome	3.41e-05	0.000183	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—TNRC6B—polycystic ovary syndrome	3.4e-05	0.000182	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—AKR1C3—polycystic ovary syndrome	3.4e-05	0.000182	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—LHB—polycystic ovary syndrome	3.37e-05	0.00018	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—PGR—polycystic ovary syndrome	3.37e-05	0.00018	CbGpPWpGaD
Diphenhydramine—CYP2C18—Metabolism—POMC—polycystic ovary syndrome	3.36e-05	0.00018	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—TNRC6B—polycystic ovary syndrome	3.35e-05	0.000179	CbGpPWpGaD
Diphenhydramine—CYP2C18—Metabolism—INS—polycystic ovary syndrome	3.34e-05	0.000179	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—LHB—polycystic ovary syndrome	3.34e-05	0.000179	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—GNAS—polycystic ovary syndrome	3.31e-05	0.000178	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—PGR—polycystic ovary syndrome	3.31e-05	0.000177	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—HSD3B2—polycystic ovary syndrome	3.29e-05	0.000176	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—HMMR—polycystic ovary syndrome	3.28e-05	0.000176	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—HSD3B2—polycystic ovary syndrome	3.26e-05	0.000175	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—GNAS—polycystic ovary syndrome	3.22e-05	0.000172	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—SULT2A1—polycystic ovary syndrome	3.19e-05	0.000171	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—AKR1C1—polycystic ovary syndrome	3.19e-05	0.000171	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—AKR1C1—polycystic ovary syndrome	3.16e-05	0.000169	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—NCOR1—polycystic ovary syndrome	3.16e-05	0.000169	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—GHRL—polycystic ovary syndrome	3.13e-05	0.000168	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—PLAT—polycystic ovary syndrome	3.13e-05	0.000168	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—HSD3B1—polycystic ovary syndrome	3.13e-05	0.000168	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	3.09e-05	0.000166	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—GNAS—polycystic ovary syndrome	3.09e-05	0.000166	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—RRM2—polycystic ovary syndrome	3.09e-05	0.000166	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—PLAT—polycystic ovary syndrome	3.08e-05	0.000165	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—GHRL—polycystic ovary syndrome	3.08e-05	0.000165	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—NCOR1—polycystic ovary syndrome	3.07e-05	0.000164	CbGpPWpGaD
Diphenhydramine—HRH1—GPCR downstream signaling—POMC—polycystic ovary syndrome	3.01e-05	0.000162	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—TH—polycystic ovary syndrome	3.01e-05	0.000161	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—CYP1A1—polycystic ovary syndrome	2.99e-05	0.00016	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—ATF1—polycystic ovary syndrome	2.99e-05	0.00016	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—YAP1—polycystic ovary syndrome	2.98e-05	0.00016	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCR downstream signaling—POMC—polycystic ovary syndrome	2.97e-05	0.000159	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—NCOR1—polycystic ovary syndrome	2.94e-05	0.000158	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—ATF1—polycystic ovary syndrome	2.94e-05	0.000157	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—SULT2A1—polycystic ovary syndrome	2.93e-05	0.000157	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	2.93e-05	0.000157	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—SLC2A4—polycystic ovary syndrome	2.93e-05	0.000157	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—TCF7L2—polycystic ovary syndrome	2.91e-05	0.000156	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—SULT2A1—polycystic ovary syndrome	2.91e-05	0.000156	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—CYP1A1—polycystic ovary syndrome	2.91e-05	0.000156	CbGpPWpGaD
Diphenhydramine—HRH1—GPCR downstream signaling—AKT2—polycystic ovary syndrome	2.9e-05	0.000155	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—TCF7L2—polycystic ovary syndrome	2.86e-05	0.000153	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—NAMPT—polycystic ovary syndrome	2.86e-05	0.000153	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—LHB—polycystic ovary syndrome	2.85e-05	0.000153	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCR downstream signaling—AKT2—polycystic ovary syndrome	2.85e-05	0.000153	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	2.84e-05	0.000152	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—RRM2—polycystic ovary syndrome	2.84e-05	0.000152	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—CYP11A1—polycystic ovary syndrome	2.83e-05	0.000151	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—RRM2—polycystic ovary syndrome	2.82e-05	0.000151	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	2.8e-05	0.00015	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—MTHFR—polycystic ovary syndrome	2.79e-05	0.00015	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—CYP1A1—polycystic ovary syndrome	2.79e-05	0.000149	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—HSD3B2—polycystic ovary syndrome	2.79e-05	0.000149	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—NGFR—polycystic ovary syndrome	2.75e-05	0.000148	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—CYP19A1—polycystic ovary syndrome	2.75e-05	0.000147	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—YAP1—polycystic ovary syndrome	2.74e-05	0.000147	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—POMC—polycystic ovary syndrome	2.74e-05	0.000147	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—PRL—polycystic ovary syndrome	2.73e-05	0.000146	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—YAP1—polycystic ovary syndrome	2.71e-05	0.000145	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—NGFR—polycystic ovary syndrome	2.71e-05	0.000145	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—MTHFR—polycystic ovary syndrome	2.71e-05	0.000145	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—AKR1C1—polycystic ovary syndrome	2.7e-05	0.000145	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—POMC—polycystic ovary syndrome	2.69e-05	0.000144	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—PRL—polycystic ovary syndrome	2.69e-05	0.000144	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—AKR1C3—polycystic ovary syndrome	2.67e-05	0.000143	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—NAMPT—polycystic ovary syndrome	2.63e-05	0.000141	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—AKT2—polycystic ovary syndrome	2.63e-05	0.000141	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—CYP17A1—polycystic ovary syndrome	2.63e-05	0.000141	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—NAMPT—polycystic ovary syndrome	2.61e-05	0.00014	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—MTHFR—polycystic ovary syndrome	2.6e-05	0.000139	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—CYP11A1—polycystic ovary syndrome	2.6e-05	0.000139	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	2.59e-05	0.000139	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—ADRB2—polycystic ovary syndrome	2.59e-05	0.000139	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—AKT2—polycystic ovary syndrome	2.59e-05	0.000139	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—CYP11A1—polycystic ovary syndrome	2.58e-05	0.000138	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	2.56e-05	0.000137	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—ADRB2—polycystic ovary syndrome	2.55e-05	0.000137	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—SULT2A1—polycystic ovary syndrome	2.49e-05	0.000133	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—GNAS—polycystic ovary syndrome	2.46e-05	0.000132	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—AKR1C3—polycystic ovary syndrome	2.45e-05	0.000131	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—AKR1C3—polycystic ovary syndrome	2.43e-05	0.00013	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—CYP17A1—polycystic ovary syndrome	2.42e-05	0.000129	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—RRM2—polycystic ovary syndrome	2.41e-05	0.000129	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—GNAS—polycystic ovary syndrome	2.4e-05	0.000129	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—CYP17A1—polycystic ovary syndrome	2.39e-05	0.000128	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—GNAS—polycystic ovary syndrome	2.36e-05	0.000127	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—NCOR1—polycystic ovary syndrome	2.34e-05	0.000125	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—YAP1—polycystic ovary syndrome	2.32e-05	0.000124	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—NCOR1—polycystic ovary syndrome	2.29e-05	0.000123	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—TH—polycystic ovary syndrome	2.27e-05	0.000122	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—PPARG—polycystic ovary syndrome	2.26e-05	0.000121	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—NCOR1—polycystic ovary syndrome	2.25e-05	0.000121	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—NRG1—polycystic ovary syndrome	2.25e-05	0.00012	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—POMC—polycystic ovary syndrome	2.23e-05	0.00012	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—NAMPT—polycystic ovary syndrome	2.23e-05	0.000119	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—INS—polycystic ovary syndrome	2.22e-05	0.000119	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—CYP1A1—polycystic ovary syndrome	2.22e-05	0.000119	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	2.22e-05	0.000119	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—SLC2A4—polycystic ovary syndrome	2.21e-05	0.000118	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—NRG1—polycystic ovary syndrome	2.21e-05	0.000118	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—CYP11A1—polycystic ovary syndrome	2.2e-05	0.000118	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—PPARG—polycystic ovary syndrome	2.2e-05	0.000118	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	2.19e-05	0.000117	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—POMC—polycystic ovary syndrome	2.17e-05	0.000116	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—INS—polycystic ovary syndrome	2.15e-05	0.000115	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—PPARG—polycystic ovary syndrome	2.11e-05	0.000113	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—TH—polycystic ovary syndrome	2.09e-05	0.000112	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—POMC—polycystic ovary syndrome	2.08e-05	0.000111	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—AKR1C3—polycystic ovary syndrome	2.08e-05	0.000111	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—CYP19A1—polycystic ovary syndrome	2.08e-05	0.000111	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—TH—polycystic ovary syndrome	2.07e-05	0.000111	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—INS—polycystic ovary syndrome	2.07e-05	0.000111	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—MTHFR—polycystic ovary syndrome	2.07e-05	0.000111	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—CYP17A1—polycystic ovary syndrome	2.05e-05	0.00011	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—SLC2A4—polycystic ovary syndrome	2.03e-05	0.000109	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—SLC2A4—polycystic ovary syndrome	2.02e-05	0.000108	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—IRS2—polycystic ovary syndrome	1.92e-05	0.000103	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—CYP19A1—polycystic ovary syndrome	1.91e-05	0.000102	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—CYP19A1—polycystic ovary syndrome	1.9e-05	0.000102	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—IRS2—polycystic ovary syndrome	1.89e-05	0.000101	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—LEP—polycystic ovary syndrome	1.88e-05	0.000101	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—GNAS—polycystic ovary syndrome	1.86e-05	9.94e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—LEP—polycystic ovary syndrome	1.85e-05	9.92e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—TH—polycystic ovary syndrome	1.77e-05	9.49e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—NCOR1—polycystic ovary syndrome	1.77e-05	9.47e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—SLC2A4—polycystic ovary syndrome	1.72e-05	9.23e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—GNAS—polycystic ovary syndrome	1.71e-05	9.14e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—GNAS—polycystic ovary syndrome	1.69e-05	9.06e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—IRS1—polycystic ovary syndrome	1.68e-05	9e-05	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—PPARG—polycystic ovary syndrome	1.68e-05	8.98e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—CYP1A1—polycystic ovary syndrome	1.68e-05	8.98e-05	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—POMC—polycystic ovary syndrome	1.65e-05	8.86e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—IRS1—polycystic ovary syndrome	1.65e-05	8.85e-05	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—INS—polycystic ovary syndrome	1.64e-05	8.81e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—NCOR1—polycystic ovary syndrome	1.63e-05	8.71e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—CYP19A1—polycystic ovary syndrome	1.62e-05	8.68e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—POMC—polycystic ovary syndrome	1.62e-05	8.66e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—NCOR1—polycystic ovary syndrome	1.61e-05	8.63e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—INS—polycystic ovary syndrome	1.61e-05	8.62e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—POMC—polycystic ovary syndrome	1.59e-05	8.53e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—INS—polycystic ovary syndrome	1.58e-05	8.48e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—MTHFR—polycystic ovary syndrome	1.56e-05	8.37e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—IGF1—polycystic ovary syndrome	1.56e-05	8.33e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—AKT2—polycystic ovary syndrome	1.55e-05	8.33e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—CYP1A1—polycystic ovary syndrome	1.54e-05	8.26e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—IGF1—polycystic ovary syndrome	1.53e-05	8.2e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—AKT2—polycystic ovary syndrome	1.53e-05	8.19e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—CYP1A1—polycystic ovary syndrome	1.53e-05	8.19e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—SERPINE1—polycystic ovary syndrome	1.48e-05	7.91e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—SERPINE1—polycystic ovary syndrome	1.45e-05	7.79e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—GNAS—polycystic ovary syndrome	1.45e-05	7.75e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—MTHFR—polycystic ovary syndrome	1.44e-05	7.7e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—MTHFR—polycystic ovary syndrome	1.42e-05	7.63e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—NCOR1—polycystic ovary syndrome	1.38e-05	7.38e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—CYP1A1—polycystic ovary syndrome	1.31e-05	6.99e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—PPARG—polycystic ovary syndrome	1.27e-05	6.79e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—POMC—polycystic ovary syndrome	1.25e-05	6.69e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—INS—polycystic ovary syndrome	1.24e-05	6.66e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—MTHFR—polycystic ovary syndrome	1.22e-05	6.52e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—IL6—polycystic ovary syndrome	1.19e-05	6.37e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—IL6—polycystic ovary syndrome	1.17e-05	6.27e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—PPARG—polycystic ovary syndrome	1.16e-05	6.24e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—PPARG—polycystic ovary syndrome	1.15e-05	6.19e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—POMC—polycystic ovary syndrome	1.15e-05	6.16e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—INS—polycystic ovary syndrome	1.14e-05	6.12e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—POMC—polycystic ovary syndrome	1.14e-05	6.1e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—INS—polycystic ovary syndrome	1.13e-05	6.07e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—VEGFA—polycystic ovary syndrome	1.02e-05	5.44e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—VEGFA—polycystic ovary syndrome	1e-05	5.36e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—PPARG—polycystic ovary syndrome	9.87e-06	5.29e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—POMC—polycystic ovary syndrome	9.73e-06	5.22e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—INS—polycystic ovary syndrome	9.68e-06	5.19e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—IL6—polycystic ovary syndrome	7.03e-06	3.76e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—IL6—polycystic ovary syndrome	6.91e-06	3.7e-05	CbGpPWpGaD
